It is now well-recognised that the need for green, economic, robust and scaleable processes is at the forefront of customer research plans for the synthesis of chiral APIs and intermediates. Tom Moody and Stefan Mix at Almac, provides an overview of how the chemical industry is under severe pressure to make their chemical processes greener, lower costs, minimise waste and shorten existing syntheses.
https://international-pharma.com/wp-content/uploads/2013/10/Biocatalysis.pdf